KLENTRYPS-BR

KLENTRYPS-BR is a specialized oral formulation designed to combat musculoskeletal pain and inflammation that can significantly impair quality of life. Each tablet contains a synergistic blend of Bromelain 90 mg, Rutoside Trihydrate 100 mg, and Trypsin 48 mg—three potent agents known for their anti-inflammatory and healing properties. Bromelain, a natural enzyme, exhibits proteolytic, anti-thrombotic, and fibrinolytic activities, helping to reduce swelling and promote tissue repair.

Rutoside strengthens capillary walls and delivers anti-edematous effects, which help minimize inflammation and protect vascular integrity. Trypsin complements the formula by rapidly digesting fibrin clots and necrotic tissue, accelerating the healing process.

KLENTRYPS-BR is indicated for the reduction of inflammatory oedema and hematoma associated with a wide range of conditions, including muscle injuries, fractures, post-caesarean sections, hysterectomies, episiotomies, surgical trauma, and sports-related injuries.

The product is marketed with the compelling call to action: “Stop inflammation & oedema... Accelerate healing,” and the tagline “Guard Against Inflammatory Oedema,” emphasizing its role in restoring comfort and mobility. With its targeted composition and proven efficacy, KLENTRYPS-BR offers a reliable solution for patients seeking fast recovery from painful inflammatory conditions.